Division of Pediatric Endocrinology, Department of Pediatrics, University of California San Francisco, Benioff Children's Hospital, San Francisco, California, USA.
Division of Endocrinology, Diabetes, Nutrition, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
J Clin Endocrinol Metab. 2021 Jan 23;106(2):305-308. doi: 10.1210/clinem/dgaa816.
Transgender and gender diverse (TGD) individuals face significant barriers to accessing health care. Recent introductions of regulatory policies at state and federal levels raise concerns over the politicization of gender-affirming health care, the risks of further restricting access to quality care, and the potential criminalization of healthcare professionals who care for TGD patients. The Endocrine Society and the Pediatric Endocrine Society have published several news articles and comments in the last couple of years supporting safe and effective gender-affirming interventions as outlined in the 2017 Endocrine Society's Clinical Practice Guidelines. The Endocrine Society Position Statement on Transgender Health also acknowledges the rapid expansion in understanding the biological underpinning of gender identity and the need for increased funding to help close gaps in knowledge about the optimal care of TGD individuals. This Policy Perspective affirms these principles in the context of pending and future legislation attempting to discriminate against TGD patients while also stressing the need for science and health care experts to inform health policies.
跨性别和性别多样化(TGD)个体在获得医疗保健方面面临重大障碍。最近在州和联邦层面出台的监管政策引发了人们对将性别认同医疗保健政治化、进一步限制获得优质护理的风险,以及可能将照顾 TGD 患者的医疗保健专业人员定罪的担忧。内分泌学会和儿科内分泌学会在过去几年中发表了多篇新闻文章和评论,支持 2017 年内分泌学会临床实践指南中概述的安全有效的性别认同干预措施。关于跨性别健康的内分泌学会立场声明也承认,对性别认同的生物学基础的理解迅速扩大,需要增加资金,以帮助缩小 TGD 个体最佳护理知识方面的差距。本政策观点在试图歧视 TGD 患者的待决和未来立法的背景下肯定了这些原则,同时强调需要让科学和医疗保健专家为卫生政策提供信息。